Biogen Announces Intent to Spin off Its Hemophilia Business
Go back to Biogen Announces Intent to Spin off Its Hemophilia Business| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 196.58 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $196.58 | 52 Week High | $333.65 | |||
| Open | $196.58 | 52 Week Low | $223.02 | |||
| Day High | $196.58 | P/E | 25.17 | |||
| Day Low | $196.58 | EPS | $7.81 | |||
| Volume | 184 | |||||
